[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 Genmab $GMAB: DARZALEX sales reached $3.67B in Q3 2025 driven by strong global demand. Genmab earns royalties from $JNJs cancer drug sales. $GMAB $JNJ #stocks #announcement"
X Link @AponiaAnalytics 2025-10-14T14:38Z 5195 followers, XXX engagements
"$GMAB Genmab Reports $3.67B in DARZALEX Worldwide Sales for Q3 2025"
X Link @MaisaCorp 2025-10-14T11:39Z 3151 followers, XXX engagements
"JUST IN: $JNJ Q3 beats + orthopaedics spin-off 💊 ✅ Adj EPS: $XXXX (vs $XXXX YoY) +16% ✅ Sales: $23.99B (beat $23.74B est) ✅ MedTech: $8.43B (+6.8% Y/Y) ✅ Guidance raised: $10.80-$10.90 EPS ✅ Sales guidance: $93.5-$93.9B Strategic shift: Spinning off orthopaedics Focus on high-growth pharma + MedTech Darzalex ($3.67B) + Stelara ($1.57B) delivering"
X Link @TomAlphaTrades 2025-10-14T10:59Z XXX followers, XXX engagements
"JOHNSON & JOHNSON STILL SEES FY ADJ OPER EPS $XXXXX TO $XXXXX 3Q MEDICINE REVENUE $15.56B EST. $15.38B 3Q STELARA REV $1.57B EST. $1.49B STILL SEES FY ADJ EPS $XXXXX TO $XXXXX 3Q SALES $23.99B EST. $23.74B 3Q DARZALEX REVENUE $3.67B EST. $3.69B $JNJ"
X Link @finsquawk_ 2025-10-14T10:23Z XX followers, XX engagements